C

Cryo-Cell International Inc
F:ZCY

Watchlist Manager
Cryo-Cell International Inc
F:ZCY
Watchlist
Price: 3.06 EUR 4.79% Market Closed
Market Cap: 25.4m EUR

Operating Margin

13.6%
Current
Improving
by 5.4%
vs 3-y average of 8.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
13.6%
=
Operating Income
$4.3m
/
Revenue
$31.7m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
13.6%
=
Operating Income
€4.3m
/
Revenue
$31.7m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Cryo-Cell International Inc
AMEX:CCEL
27.1m USD
Loading...
US
CVS Health Corp
NYSE:CVS
103.5B USD
Loading...
US
Cigna Corp
NYSE:CI
73.3B USD
Loading...
US
Cigna Group
XMUN:CGN
62B EUR
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
26.8B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
21.4B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.3B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
20.5B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14.5B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.6B EUR
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
11.3B AUD
Loading...
No Stocks Found

Market Distribution

In line with most companies in the United States of America
Percentile
67th
Based on 14 112 companies
67th percentile
13.6%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Cryo-Cell International Inc
Glance View

Market Cap
25.4m EUR
Industry
Health Care

Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 83 full-time employees. The firm operates through three segments: The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use; the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens around the world for the benefit of newborn babies and possibly other members of their families. Its processing and storage of specimens is handled from its facility in Oldsmar, Florida.

ZCY Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
13.6%
=
Operating Income
$4.3m
/
Revenue
$31.7m
What is Cryo-Cell International Inc's current Operating Margin?

The current Operating Margin for Cryo-Cell International Inc is 13.6%, which is above its 3-year median of 8.2%.

How has Operating Margin changed over time?

Over the last 3 years, Cryo-Cell International Inc’s Operating Margin has increased from 9.4% to 13.6%. During this period, it reached a low of -42% on Feb 29, 2024 and a high of 14.5% on Nov 30, 2023.

Back to Top